We sequenced 170 cancer-related genes, and variants were shown to be enriched in PIK3CA and TP53. Recurrent germline mutations of MLH1 were found in 13.8%, with a significantly high TP53 mutations rate. This evidence concerns the gene MLH1 and cancer.